| Literature DB >> 22851917 |
Shang-Kwei Wang1,2, Mu-Keng Hsieh3, Chang-Yih Duh1,3.
Abstract
In order to search for new bioactive substances from marine organisms, we have investigated the acetone extracts of the soft coral Sarcophyton ehrenbergi collected at San-Hsian-Tai, Taitong County, Taiwan. Chromatographic fractionation of the extracts of the octocoral S. ehrenbergi led to the isolation of three new cembranoids, (+)-12-ethoxycarbonyl-11Z-sarcophine (1), ehrenbergol A and B (2 and 3). The structures of these isolated metabolites were elucidated through extensive spectroscopic analyses. Moreover, metabolites 1-3 were evaluated in vitro for their cytotoxicity towards selected cancer cell lines and antiviral activity against human cytomegalovirus (HCMV).Entities:
Keywords: Sarcophyton ehrenbergi; anti-HCMV; cembranoids; cytotoxicity
Mesh:
Substances:
Year: 2012 PMID: 22851917 PMCID: PMC3407922 DOI: 10.3390/md10071433
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Soft coral Sarcophyton ehrenbergi.
Figure 2Structures of compounds 1–4.
NMR data for compound 1.
| Position | HMBC | COSY | NOESY | ||
|---|---|---|---|---|---|
| 1 | 160.7, C | ||||
| 2 | 5.57, dd (10, 2.0) | 78.2, CH | 3, 17 | 18 | |
| 3 | 5.08, d (10.4) | 121.1, CH | 5, 18 | 2, 18 | 5a |
| 4 | 144.5, C | ||||
| 5a | 2.39, m | 37.7, CH2 | 3, 4, 6, 18 | 5b, 6a | 3, 5b, 7 |
| 5b | 2.41, m | 3, 4, 6, 18 | 5a, 6a | 5a,18 | |
| 6a | 1.92, m | 22.9, CH2 | 6b, 5a, 5b | 6b | |
| 6b | 1.72, m | 6a, 7 | 6a,18, 19 | ||
| 7 | 2.56, br d (6.4) | 62.4, CH | 6 | 6b | 9a, 10a |
| 8 | 61.3, C | ||||
| 9a | 0.97, m | 38.2, CH2 | 10 | 9b | 9b, 11 |
| 9b | 2.22, m | 11 | 9a, 10a, 10b | 7, 9a, 19 | |
| 10a | 2.11, m | 25.9, CH2 | 12 | 9a, 10b | 7, 10b |
| 10b | 2.19, m | 9a, 10a, 11 | 10a | ||
| 11 | 6.80, dd (10.4, 4.8) | 142.0, CH | 10, 13, 20 | 10a | 9b |
| 12 | 131.1, C | ||||
| 13 | 2.36, m | 25.2, CH2 | 12, 20 | 14b | |
| 14a | 2.50, m | 27.0, CH2 | 1, 2, 15 | 14b | 14b |
| 14b | 2.11, m | 13a, 14a | 14a | ||
| 15 | 124.2, C | ||||
| 16 | 174.4, C | ||||
| 17 | 1.90, s | 8.6, CH3 | 1, 15, 16 | 2 | |
| 18 | 1.87, s | 15.3, CH3 | 3, 4, 5 | 3 | 2, 5b |
| 19 | 1.30, s | 16.8, CH3 | 7, 8, 9 | 6b, 9b | |
| 20 | 166.9. C | ||||
| 21 | 4.23, m | 60.8, CH2 | 20 | 22 | 22 |
| 22 | 1.33, t (7.2) | 14.3, CH3 | 21 | 21 | 21 |
Spectra were measured in CDCl3 (400 MHz); Spectra were measured in CDCl3 (100 MHz).
Figure 3COSY and HMBC correlations of compounds 1–3.
Figure 4NOESY correlations of compound 1.
NMR data for compound 2.
| Position | HMBC | COSY | NOESY | ||
|---|---|---|---|---|---|
| 1 | 147.1, C | ||||
| 2 | 6.53, d (11.0) | 118.4, CH | 4, 14, 15 | 3 | 16, 17, 18 |
| 3 | 6.08, d (11.0) | 123.8, CH | 5, 18 | 2, 18 | 5a, 7, 13a |
| 4 | 135.8, C | ||||
| 5a | 2.12, m | 37.8, CH2 | 3 | 5b, 18 | 3, 5b |
| 5b | 1.97, m | 3 | 5a, 6b, 18 | 5a, 6b, 18 | |
| 6a | 1.94, m | 25.5, CH2 | 7 | 6b, 7 | 6b |
| 6b | 1.17, m | 5b, 6a, 7 | 5b, 6a,19 | ||
| 7 | 2.67, dd (10.8, 2.8) | 62.1, CH | 6a, 6b | 3, 9a | |
| 8 | 60.6, C | ||||
| 9a | 0.85, td (12.4, 4.0) | 39.7, CH2 | 8, 19 | 9b, 10a, 10b | 9b, 7 |
| 9b | 1.95, m | 8, 10, 19 | 9a, 10a, 10b | 9a, 19 | |
| 10a | 2.16, m | 26.7, CH2 | 9, 10b, 11 | 10b | |
| 10b | 1.75,m | 9, 11, 12 | 9, 10a, 11 | 10a, 19 | |
| 11 | 6.89, dd (10.4, 6.8) | 141.1, CH | 20 | 10a, 10b | 9 |
| 12 | 133.9, C | ||||
| 13a | 2.26,m | 28.4, CH2 | 3, 13b, 14b | ||
| 13b | 2.38, m | 11, 12, 20 | 13a | ||
| 14a | 2.52, m | 28.6, CH2 | 12 | 14b, 17 | |
| 14b | 2.24, m | 12 | 14a | ||
| 15 | 73.6, C | ||||
| 16 | 1.33, s | 29.5, CH3 | 1, 15, 17 | 2 | |
| 17 | 1.44, s | 29.3, CH3 | 1, 16, 17 | 2 | |
| 18 | 1.58, s | 15.6, CH3 | 3, 4, 5 | 3, 5a, 5b | 2, 5b |
| 19 | 1.04, s | 15.6, CH3 | 7, 8, 9 | 6b, 9b, 10b | |
| 20 | 167.6, C | ||||
| 21 | 3.42, s | 51.2, CH3 | 20 |
Spectra were measured in CDCl3 (400 MHz); Spectra were measured in CDCl3 (100 MHz).
Figure 5NOESY correlations of compound 2.
NMR data for compound 3.
| Position | HMBC | COSY | NOESY | ||
|---|---|---|---|---|---|
| 1 | 150.2, qC | ||||
| 2 | 5.89, br d (5.0) | 119.6, CH | 4, 14, 15 | 3 | 3, 15, 16, 18 |
| 3 | 5.99, br d (5.0) | 122.3, CH | 1, 5, 18 | 2, 18 | 2, 5a |
| 4 | 137.1, qC | ||||
| 5 | 2.16, m | 39.6, CH2 | 3, 4, 6, 7 | 6a, 6b | 3, 7, 6b, 18 |
| 6a | 1.42, m | 26.5, CH2 | 8 | 5a, 5b, 6b | 5b, 19 |
| 6b | 1.69, m | 4, 5, 7 | 5a, 5b, 6a | ||
| 7 | 3.40, d (7.6) | 85.1, CH | 5, 6, 8, 9, 11, 19 | 5a, 9a | |
| 8 | 80.7, qC | ||||
| 9a | 1.73, m | 35.4, CH2 | 9b, 10a, 10b | 7, 9b, 11 | |
| 9b | 2.83, dt (12.4, 4.0) | 19 | 9a, 10a, 10b | 9a, 10b, 19 | |
| 10a | 1.56, m | 23.0, CH2 | 10b | 10b, 11 | |
| 10b | 1.39, m | 10a | 10b, 20 | ||
| 11 | 3.32, dd (11.2, 2.0) | 80.1, CH | 7, 12, 20 | 10a, 10b | 9a, 10a, 14a |
| 12 | 73.0, qC | ||||
| 13a | 1.46, m | 41.0, CH2 | 20 | 13b, 14a | |
| 13b | 1.80, m | 12, 20 | 13a | 17, 20 | |
| 14a | 2.22, m | 24.0, CH2 | 1, 2 | 13a, 13b, 14b | 3, 11 |
| 14b | 1.77, m | 13 | 14a | ||
| 15 | 2.28, m | 35.2, CH | 16, 17 | 16, 17 | 2, 16, 17 |
| 16 | 1.08, d (7.2) | 22.0, CH3 | 1, 15, 17 | 15 | 2, 15 |
| 17 | 1.10, d (6.4) | 22.6, CH3 | 1, 15, 16 | 15 | 2, 13b, 15 |
| 18 | 1.64, s | 17.2, CH3 | 3, 4, 5 | 3 | 2, 5b |
| 19 | 1.50, s | 17.1, CH3 | 7, 8, 9 | 6b, 9b | |
| 20 | 1.01, s | 23.8, CH3 | 11, 12, 13 | 10b, 13b | |
| OAc | 1.67, s | 169.2, qC | |||
| 21.9, CH3 |
Spectra were measured in C6D6 (400 MHz); Spectra were measured in C6D6 (100 MHz).
Figure 6NOESY correlations of compound 3.
Cytotoxicit and anti-HCMV activity of 1–3.
| Compounds | ED50 (μg/mL) | ||||
|---|---|---|---|---|---|
| A549 | HT-29 | P-388 | HEL | Anti-HCMV | |
| 1 | 20.8 | >50 | 5.8 | >50 | 60 |
| 2 | >50 | >50 | 7.4 | >50 | 46 |
| 3 | 10.2 | >50 | 4.7 | >50 | 5.0 |